Literature DB >> 17298768

Management of painful neuropathies.

Harry J Gould1.   

Abstract

Inadequately assessed and poorly managed pain contributes both to high general medical cost and to increasing numbers of societal problems. A large determining factor of inadequate pain care is the lack of understanding about the complex nature of pain and of a rational approach to its assessment and treatment. The less than adequate assessment of neuropathic pain and its relatively poor response to typical analgesic medications are major determinants to the undertreatment of pain. Other than the important management concept of treating the underlying cause, current approaches to the treatment of pain in general, and neuropathic pain in particular, have shifted away from treatment of individual syndromes toward the identification and management of common symptoms and the mechanisms upon which such symptoms are presumed to be based. This article summarizes the features of neuropathic pain that commonly appear in most peripheral neuropathies, regardless of the mechanism of injury, and provides an approach for the selection of treatment.

Entities:  

Year:  2007        PMID: 17298768     DOI: 10.1007/s11940-007-0033-2

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  59 in total

1.  Cognitive-Behavioral self-help for chronic pain.

Authors:  Luis F Buenaver; Lynanne McGuire; Jennifer A Haythornthwaite
Journal:  J Clin Psychol       Date:  2006-11

Review 2.  New targets for neuropathic pain therapeutics.

Authors:  Ross A Kinloch; Peter J Cox
Journal:  Expert Opin Ther Targets       Date:  2005-08       Impact factor: 6.902

Review 3.  Combined cannabinoid therapy via an oromucosal spray.

Authors:  Jordi Perez
Journal:  Drugs Today (Barc)       Date:  2006-08       Impact factor: 2.245

Review 4.  Oxcarbazepine, topiramate, zonisamide, and levetiracetam: potential use in neuropathic pain.

Authors:  David R P Guay
Journal:  Am J Geriatr Pharmacother       Date:  2003-09

5.  Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study.

Authors:  D K Kochar; P Garg; R A Bumb; S K Kochar; R D Mehta; R Beniwal; N Rawat
Journal:  QJM       Date:  2005-01

6.  Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study.

Authors:  G J McCleane
Journal:  Anesth Analg       Date:  1999-10       Impact factor: 5.108

7.  A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.

Authors:  C P Watson; K L Tyler; D R Bickers; L E Millikan; S Smith; E Coleman
Journal:  Clin Ther       Date:  1993 May-Jun       Impact factor: 3.393

8.  Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.

Authors:  M Rowbotham; N Harden; B Stacey; P Bernstein; L Magnus-Miller
Journal:  JAMA       Date:  1998-12-02       Impact factor: 56.272

Review 9.  Cognitive-behavioral approach to the treatment of chronic pain patients.

Authors:  Dennis C Turk
Journal:  Reg Anesth Pain Med       Date:  2003 Nov-Dec       Impact factor: 6.288

Review 10.  Painful peripheral neuropathy and its nonsurgical treatment.

Authors:  Gil I Wolfe; Jaya R Trivedi
Journal:  Muscle Nerve       Date:  2004-07       Impact factor: 3.217

View more
  1 in total

Review 1.  Chronic Daily Headache: Mechanisms and Principles of Management.

Authors:  Amy W Voigt; Harry J Gould
Journal:  Curr Pain Headache Rep       Date:  2016-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.